Papi, Alberto <br/><br/>
Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study.  [electronic resource] 

 -  Respiratory medicine  02 2019 
 - 37-43 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-3064 
<br/><br/><label>Standard No.: </label>10.1016/j.rmed.2018.12.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcysteine--administration & dosage<br/>Administration, Inhalation<br/>Administration, Oral<br/>Adrenal Cortex Hormones--administration & dosage<br/>Adrenergic beta-2 Receptor Agonists--administration & dosage<br/>Aged<br/>Bronchodilator Agents--therapeutic use<br/>China--epidemiology<br/>Disease Progression<br/>Expectorants--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Placebos--administration & dosage<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Severity of Illness Index<br/>Smoking--adverse effects